Announcements Trials
Browse Landscape

Phase

Phase 3 4

Status

Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Conditions

Leiomyoma 4Menorrhagia 2

Interventions

ulipristal acetate 20Uterine Myomectomy 19telapristone acetate 18vilaprisan 12relugolix 12Leuprolide 11Uterine Artery Embolization 10estradiol, norethindrone drug combination 9asoprisnil 9Estradiol 8elagolix 7Tranexamic Acid 7Mifepristone 7Bupivacaine 7ulipristal 6Norethindrone Acetate 6Hysterectomy 6Saline Solution 5linzagolix 4epigallocatechin gallate 4Sodium Chloride 4Misoprostol 4Letrozole 4Vitamin B 6 3Tablets 3Surveys and Questionnaires 3Sugars 3Radiofrequency Ablation 3Lidocaine 3Hysteroscopy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Leiomyoma × linzagolix × Clear all
NCT05445167 2025-11-25

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain

Kissei Pharmaceutical Co., Ltd.

Phase 3 Completed
89 enrolled

Leiomyoma

NCT05440383 2025-03-14

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia

Kissei Pharmaceutical Co., Ltd.

Phase 3 Completed
287 enrolled

Leiomyoma

NCT03070899 2021-06-09

PRIMROSE 1

ObsEva SA

Phase 3 Completed
526 enrolled

Leiomyoma, Menorrhagia

NCT03070951 2021-03-05

PRIMROSE 2

ObsEva SA

Phase 3 Completed
511 enrolled

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡